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THE NEPHROTIC SYNDROME
DONOVAN F . H I N C H M A N ,

M.D.*

It is the purpose of this paper to review our 25 years' experience in the treatment
of lipoid nephrosis in children. Included in this series are 73 cases that fulfilled the
criteria of edema, proteinuria, hypoproteinemia and hyperlipemia. These were all
chfldren ranging in age from 12 months to 11 years at the onset of their edema, with
no significant hematuria, hypertension or azotemia.
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NEPHROTIC PATIENTS ACCORDING TO AGE OF ONSET OF EDEMA

RESULTS
The first five patients received supportive treatment only, including plasma and
whole blood transfusions, paracenteses, etc. Three died of intercurrent infection, chiefly
pneumococcic peritonitis. Two could not be followed.
The next 30 patients were treated, in addition, with more or less regulated courses
of prophylactic antibiotics or sulfonamides. These drugs were also given in therapeutic
dosage during acute exacerbations of edema.
•Resident, Department of Pediatrics.
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Since 1950, there have been 30 patients treated with the steroid hormones during
acute exacerbations of their edema." These have included ACTH, cortisone, hydrocortisone and prednisone. They were routinely given large doses with abrupt cessation of
therapy after 10-14 days.'''-'' Diuresis usually ensued during the administration or
shortly after withdrawal of the hormone. Other evidence of remission was usually
present; decrease in proteinuria, decrease in serum cholesterol and rise in the serum
proteins.'"
Nitrogen mustards have not been used in the treatment of nephrosis in children
at this hospital.*
Recently there has been a growing interest in the use of prolonged steroid therapy
in nephrosis. Some have suggested that, after an initial course of intensive steroids,
hydrocortisone be given 3 consecutive days each week for as long as one year or
more.'-' Others would use discontinuous therapy only until the urine and serum proteins
have been normal for 2-3 months." There are several variations on this same approach.
We have attempted this general program on 8 patients. The results of these may be
Total No
Cases

GROUPS

Recovered

Dead

Active
When Last
Seen

Lost

Albumin
Only

5

0

3

0

2

0

I I Before Steroids to 1950

30

11

9

0

8

2

I I I Steroids for Edema Only

30

9

13

1

6

1

8

1

1

6

0

0

8

6

2

0

0

0

I Before Antibiotics to 1939

I V Protracted Steroids Therapy
V Hyposensitized

TABLE I
NEPHROSIS STATUS — NOVEMBER, 1956 — 73 CASES
Note: Cases in Group V were also in Groups III and IV,

seen in Table I , We plan to follow the following proposed therapy schedule:'
A. Steroid therapy will be instituted as soon as the diagnosis of nephrosis is made
(the four cardinal features of edema, proteinuria, hypoproteinemia and hyperlipemia (hypercholesteremia) are demonstrated, with or without hypertension, hematuria or azotemia).
B. Basic Course of Steroids will consist of one of the following:
1. Cortisone orally 300-400 mgm. daily for ten days (ACTH wfll be given on
the 9th, 10th and 11th days, in a dosage of 40 units, 30 units and 20 units
respectively).
2. Two ten
be used
cessation
separated

day courses of cortisone (as described in Number 1 above) may
in certain patients in whom- the initial course does not produce
or significant diminution of proteinuria. The two courses will be
by an interval of five days.
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3. ACTH 40 units (for patients under two years) to 80 units (for patients over
two years of age) in the form of a long-acting preparation given once or
twice daily (depending upon the preparation used) for 21 to 28 consecutive
days.
C. Maintenance Steroid Therapy:
1. Cortisone 300 mgm. orally on each of three consecutive days of each week
until the patient is free of proteinuria for two months.
D. Supplemental
Medications:
1. Antibiotics;
(a) During intensive steroid therapy whfle the patient is hospitalized, full
therapeutic dosage (10-15 mgm. per pound per day) of oxytetracycline
or tetracycline will be given.
(b)

2.

During maintenance steroid therapy, tetracycline or oxytetracycline wfll
be given in a dosage of 5 mgm. per pound per day in two divided doses.
If an infection develops in spite of this prophylatic therapy, the amount
of antibiotic will be increased to full therapeutic dosage (10-15 mgm.
per pound per day) for a minimum of five days and then reduced to
the prophylactic dose if the infection has subsided,

Potassium salts;
(a) During intensive steroid therapy and throughout periods of diuresis, 3.0
gm. per day of potassium salt (either potassium chloride or a triple
mixture of potassium-acetate, bicarbonate and citrate) will be given in
three divided doses daily.
(b) While on maintenance steroid therapy, 2.0 to 3.0 gm. of either potassium
salt will be given daily in three divided doses.

3. Calcium salts;
Calcium lactate is given in a dosage of 4.0 gm. per day in three divided
doses as long as patients are on steroid therapy. (Inclusion of caelum salts
in the supplementary medications is optional).
E. Supportive Therapy and Program:
1. Diet;
(a) A no-added salt but otherwise general diet is advised. Protein is offered
in an amount usual for the patient's age but is not forced.
2. Activity is tolerated, including regular school attendance when the general
condition of the patient permits.
3. Plasma Expanders;
Blood, salt-free concentrated serum albumin or plasma is used when indicated
because of intractible edema, or when steroid therapy is contraindicated or
whenever it seems feasible to give additional supportive therapy.
4.

Abdominal paracentesis will be used in recurrent or complicated cases when
abdominal distress becomes extreme.
33
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DISCUSSION
Table I is a summary of our overall results and present status in therapy. Our
results, since 1939, have compared favorably with Riley and others.''"
The survival rates in patients treated only with antibiotics and those treated with
steroids for edema only are closely parallel. There are indications that those treated
with prolonged intermittent cortisone will have a significantly improved survival rate.
It is of interest to note that, in the review of the eight children who were desensitized to bacterial protein, six can be classed as definite cures and only two died. These
are too few cases to be of statistical significance but this form of treatment should
be investigated further. There were in this series 30% with a definite history of allergy,
either in the child or the family. The relatively gratifying results with hyposensitization
to the bacterial protein lends support to the hypothesis that childhood lipoid nephrosis
may be related to antigen-antibody reaction or to the Schwartzman phenomenon.'
SUMMARY
A review is made of the treatment and clinical course of 73 children with the
nephrotic syndrome.
Results of treatment with steroids given for edema only have been similar to the
use of antibiotics alone.
The use of protracted hormone therapy appears to have promising possibflities.
A definite therapy schedule has been set up at this hospital.
Further investigation in the use of hyposensitization to bacterial protein in childhood
nephrosis is suggested.
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